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Abstract
Objective: To assess the frequency of spontaneous bacterial peritonitis 
(SBP) in the Medical intensive care unit (ICU) of Zagazig University 
Hospital, identify the causative organisms, their susceptibility to 
antimicrobials, and to determine risk factors and clinical outcomes.
Methods: One hundred and eighty-nine ascitic patients suffered of 
liver cirrhosis were included in this prospective study. Medical history, 
physical examination, radiological reports and assessment of disease 
severity were done. Diagnostic paracentesis was performed. Ascitic 
fluid was subjected to chemical, hematological and bacteriological 
investigations. Isolated bacteria and their antibiotic susceptibility 
pattern were identified using standard methods. 
Results: Frequency of SBP in ascitic patients due to liver cirrhosis 
was 56.1%. Classic SBP was diagnosed in 47.2% of cases and the 
remaining 52.8% were found to be culture negative neutrocytic 
ascites (CNNA). Comparison of the mean ± standard deviation (SD) 
of clinical and demographic characteristics for SBP versus non SBP 
revealed significant association with hepatocellular carcinoma (HCC) 
and with beta blockers(BB). Comparison between mean ± SD of 
clinical, biochemical and microbiological characteristics for SBP variants 
revealed significant association with HCC, total leucocytic count and 
positive culture. Significant symptoms and signs were observed with 
fever, hypotension and abdominal pain. E-coli was the most frequently 
isolated bacteria (56%), followed by Klebsiella pneumoniae 24% and 
Staphylococcus aureus 20%. Gentamicin was the most effective 
antibiotic in- vitro against K. pneumonia and E. coli isolates, while all S. 
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Introduction
Spontaneous bacterial peritonitis (SBP) is a com-
mon and severe complication of cirrhotic patients 
with ascites characterized by spontaneous infec-
tion of ascitic fluid which occurs in the absence 
of any infection or perforation of intra- abdomi-
nal organs [1]. Most episodes of SBP are caused 
by gram-negative bacteria, but in hospital setting, 
gram positive-bacteria have been isolated with an 
increasing frequency in recent years. Antimicrobial 
activity of the ascitic fluid plays very important role 
in the development of SBP [2].The clinical spectrum 
of SBP is very variable and relatively low percent-
age of patients show the complete typical features 
of acute peritoneal infection with diffuse abdomi-
nalpain, rebound tenderness, and reduced bowel 
sounds. Fever is a frequent but not universal finding. 
However, it may be the only clinical sign in a large 
proportion ofpatients. In other cases, infection is 
manifested by hepatic encephalopathy (HE), wors-
ening of liver and/or renal function or septic shock, 
while the peritoneal signs maybe weak or absent. 
In approximately 13% of cases, SBP is asymptomatic 
[3]. A sample of ascitic fluid should be obtained 
routinely in all patients with cirrhosis and ascites ad-
mitted to hospital and in those hospitalized patients 
who develop signs or symptoms suggestive of SBP. 
The diagnosis of SBP is made when total white cell 
count in the peritoneal fluid is greater than 500/
mm3 and polymorph nuclear leucocyte count (PMN) 
is greater than 250/mm3. A positive bacterial culture 
of the ascitic fluid is not required for the diagnosis 
of SBP [4]. When the ascitic fluid PMN are morethan 
250/mm3 and the ascitic fluid culture is positive, the 
case is identified as culture positive/classic SBP, if 
the ascitic fluid PMN are more than 250/mm3 and 
the ascitic fluid culture is negative, the condition 
is identified as culture negative neutrocytic ascites 
(CNNA) and when ascetic fluid PMN are less than 
250/mm3 and the ascitic fluid culture is positive, the 
case is diagnosed as bacterial ascites[5].Treatment of 
spontaneous bacterial peritonitis has to be started 
immediately after diagnosis and therefore is usually 
empirical since culture results are not available at 
this time point. However, none of the international 
guidelines to date differentiates between nosoco-
mial and community-acquired SBP with regard to 
their antibiotic treatment. This may be associated 
with serious consequences since nosocomial infec-
tions are associated with high rates of multiresistant 
bacteria and mortality [6]. The efficacy and role of 
prophylactic antibiotics is highly impotant [7].
aureus isolates were susceptible for vancomycin. Higher mortality rate 
was found in patients with SBP versus those with non-SBP (p=0.024). 
Predictors of mortality among patients with SBP were related to old 
age and high End-Stage Liver Disease according to MELD score. 
Conclusion: SBP is frequently encountered in the medical ICU as a life 
threatening complication of liver cirrhosis. Early diagnosis and prompt 
management guarantee improved prognosis. 
Keywords: Spontaneous bacterial peritonitis, Neutrocytic ascites, 
bacterial agents & antibiotic resistance
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Epidemiological studies about SBP in medical ICUs 
in Sharkia Governorate are scarce. To the best of our 
knowledge there is no study about the magnitude 
of this problem in our hospital. Therefore, this study 
has been done to assess the frequency of SBP and 
its variants in the Medical ICU of Zagazig University 
Hospital, to identify the causative bacterial flora and 
their susceptibility profile to antimicrobials, and to 
determine risk factors for acquisition of this clini-
cal condition. Another objective was to assess the 
clinical outcomes; and to determine their predictors. 
Patients and Methods 
A total of 189 patients hospitalized in the medi-
cal ICU of the Internal Medicine Department of Za-
gazig University Hospital were enrolled in this cross 
sectional study.
This hospital is a university-affiliated and located 
in Zagazig city; the capital of Sharkya Governorate 
in the eastern province of Egypt.
Informed written consent was obtained from 
each enrolled case, and approval for conducting the 
study was obtained from the Institutional Review 
Board, Zagazig Faculty of Medicine. Inclusion criteria 
included diagnosis of ascites with complicating liver 
cirrhosis, and age of ≥ 18 years. Exclusion criteria 
included antibiotic use in the previous two weeks, 
failure to obtain ascitic fluid specimen, refusal of pa-
tients to participate in the study and incomplete pa-
tients’ data (biochemical, clinical). A complete medi-
cal history was collected from each patient. Data 
included personal history, signs and symptoms (fe-
ver, abdominal pain, GIT bleeding, HE), medications 
(proton pump inhibitors “PPI” and beta- blockers in 
the previous two weeks), and underlying diseases 
(e. g., diabetes, mellitus, ischemic heart disease, 
chronic obstructivepulmonary disease and renal 
disorders). All the patient were subjected to thor-
ough physical examination with emphasize being 
placed on abdominal examination, routine labora-
tory investigations and radiological studies. Disease 
severity was assessed using Child –Pugh score and 
modified Child-Pugh classification of severity of liver 
disease [8], and MELD score. Paracentesis was car-
ried out using a 23-gauge sterile needle under local 
anesthesia with lidocaine. Ascitic fluid samples were 
collected under complete aseptic technique. Ten ml 
of the fluid was inoculated immediately into aerobic 
and anaerobic blood culture bottles (Oxoid, Signal 
Blood Culture System)) at the bedside. Two ml of 
blood was added to an EDTA vacutainers (Tradekey, 
Egypt) to test for gross appearance, cell counts and 
differential count and two ml were added to a hep-
arinized tube for chemistry testing [9].Subcultures 
of the blood culture bottles were made on blood 
agar and MacConkey’sagar (Oxoid Basingstoke, UK) 
and were incubated aerobically and anaerobically 
at 37°C for 24 hours. Growing colonies were iden-
tified by conventional microbiologic tests, and by 
API 20 E (Bio-Merieux, France) for gram negative 
aerobic bacilli. All isolated strains were tested for an-
timicrobial sensitivity test by standardized disk diffu-
sion technique [10]. The following antibiotics were 
used: amikacin 30 ug, amoxicillin/clavulinate 20/10 
ug, ampicillin/sulbactam 10/10 ug, azteronam 30 
ug, cefepime 30 ug, cefotaxime 30 ug,ceftazidime 
30 ug, ceftriaxone 30 ug, cefuroxime 30 ug, gen-
tamycin 10 ug, imipenem10 ug and meropenem 10 
ug. 
Statistical Analysis: Data were collected, en-
tered and checked to SPSS program version 17. 
Data were expressed as mean ± standard deviation 
in quantitative variables, number and percentage 
for qualitative variables.Categorical data were com-
pared using the chi-square test or fisher’s exact test 
and are expressed as percentage. Statistical signifi-
cance was defined as P less than 0.05. Continuous 
covariates that were not normally distributed were 
categorized using standard quartiles.The logistic 
regression model was used to perform both the 
univariate and multivariate analysis to examine as-
sociations between outcomes and clinical and bio-
chemical variable.
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Results
A total of 189 patients were the subject of this 
study, 118 were males and 71 were females. Their 
ages ranged from 30- 94 years, and 67 were smok-
ers. MELD score ranged from 6- 54, and 102 had 
associated infection. Random blood glucose level 
(mean± SD) was 184.5± 105 (Table 1). All other 
Risk factors, signs and symptoms and biochemi-
cal and hematological analysis of ascitic fluid are 
shown in Table 1. Out of the 189 patients with 
ascites due to liver cirrhosis, 106 were diagnosed 
as SBP; 50 were classic SBP and 56 were CNNA. 
Biological characteristics of ascitic fluid samples in 
patients with SBP and number and type of each 
bacterial isolates are shown in Table 2. Gentamicin 
was the most effective antibiotic in- vitro against 
K. pneumonia and E. coli, while S. aureus. was 
100% susceptible to vancomycin. The susceptibility 
of tested antibiotics is shown in Table 3. When the 
mean± SD of clinical and demographic character-
istics for SBP and non-SBPwere compared, 36.6% 
of patients had hepatocellular carcinoma; 63.6% of 
them were having SBP and 32.4% were negative. 
Beta blockers were used by 21.7% of study group, 
mainly by those diagnosed to have non SBP. Patients 
with SBP were more likely to presentwith fever than 
those withnon SBP, whereas the latter group of 
patients were morelikely to present with hypoten-
sion than the former group. The rest of compared 
variableare shown in Table 4. Comparison between 
characteristics of SBP variants showed that mortality 
is higher in patients with SBP versus non-SBP. No 
statisticallysignificant difference occurred between 
SBP and non-SBP regarding ICU stay. The univari-
ate analysis for risk factors for mortality among SBP 
patients revealed thatage andMELDscore were the 
only significant factors for mortality (p 0.001 and 
p0.003, respectively). When the two variables were 
introduced into a multivariate regressionmodel, they 
remained as independent risk factor for mortality 
(Table 4). Comparison of most important clinical, 
biochemical and microbiological characteristics for 
SBP variants is shown in Table 5.
Table I.  Clinical and demographic characteristics 
and outcomes of study population
Total patients
No=189
Characteristics
 
118(62.4)
71 (37.6)
Sex 
Male: N (%)
Female: N (%)
60.3±13 (30-94)Age(years) mean± SD (range)
67 (35.4)Smokers: N (%)
21.3±9.7(6-54)MELD score mean± SD (range)
102 (54)Associated infection: N (%)
184.5±105Random blood glucose(mg/dl) 
mean± SD
71(36.6 )
12(6.3 )
41(21.7 )
67(35.4 )
Risk factors:
HCC: N (%)
PPI: N (%)
BB: N (%)
Diabetes: N (%)
88(46.6 )
78(41.3 )
23(12.2 )
42(22.2 )
31(16.4 )
Signs and symptoms:
 Fever: N (%)
 Abdominal pain: N (%)
 GI bleeding: N (%)
 HE: N (%)
  Hypotension at presentation: N (%)
925.8±1232(100-8000)
170(25-2200)
1320(71-8800)
174.7±113
110(30-914)
Biochemical and hematological 
analysis of ascitic fluid:
Total leucocytic count (Cells\µl): 
mean± SD (range)
Neutrophile cells\µl: (median- range)
Total protein g\dl (median- range)
Glucose (mg\dl): mean± SD 
LDH(IU\l): median-range (Range)
9.7±2.3(7-15)Child-Pugh score: mean± SD (range)
18.1±6.7Prothrombin time(seconds):  
mean± SD
1.5±0.6Pro Time INR (mean± SD)
52(27.5 )Mortality: N (%)
5.4±1.8(3-9)ICU stay(days):mean±SD(Range)
Abbreviations; MELD: Model for End stage Liver Disease, PPI: 
proton pump inhibitor, HCC: hepatocellular carcinoma, BB: beta 
blocker, GI: gastro-intestinal, HE: hepatic encephalopathy
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Discussion
Spontaneous bacterial peritonitis (SBP) is one of 
the most common and life-threatening problems 
of liver cirrhosis. The frequency of SBP in patients 
admitted to our Medical ICU with ascites and com-
plicating liver cirrhosis is 56.1% . Remarkably, this 
rate is higher than rates from other parts of the 
world [1, 11, 12]. 
Cases of SBP encountered in this work where 
either the classical or CNNA type, which goes in 
accord with the findings of Iqbal et al [11]. Our rates 
of the classical and the CNNA types are also com-
parable to those estimated by Amjad et al. (13), 
and Nepal et al. (14). Concerning bacterascitis type; 
whereas no cases were diagnosed during the cur-
rent work, it has been stated to range between 
3.7% and 11.1% in other studies (13- 14). Differ-
ences in the occurrence of bacterascitic cases may 
be due to differences in the severity of the under-
lying liver disease or in timing of paracentesis or 
culture methods. 
Investigations are required for accurate diagno-
sis. The first step is diagnostic paracentesis. Ascitic 
fluid culture is also needed to identify the causative 
agents. 
Dissimilar to secondary peritonitis, SBP are usu-
ally monomicrobic [15]. The predominance of gram-
negative bacteria in our work coincides with other 
reports [16]. These results support the theory of bac-
terial translocation as the most probable mechanism 
responsible for the occurrence of SBP in cirrhotic 
ascitic patients. Translocation of intestinal bacteria 
is somewhat organism-specific; gram-negative bac-
teria translocate more efficiently than gram-positive 
bacteria or anaerobes [17].
Table 2.  Biological characteristics of ascitic fluid in 
patients with SBP
SBP No=106
mean± SD
Characteristics
 
900 (500-8000)
Total leucocytic count in ascitic 
sample (cells\µl): median-range
 
450(250-2200)
Neutrophil count (cells\µl):  
median-range
1381(71-8800)Total protein (mg\dl): median-range
176±120Glucose (mg\dl): mean± SD
111(30-914)LDH (IU\l): median-range
28 (56 )
12 (24 )
10 (20 )
Causative bacteria isolates
E. coli: N (%)
Klebsiella: N (%)
Staph. aureus: N (%)
Table 3. Antibiotic susceptibility of the isolated bacteria 
Bacteria  
(N ) tested
N (%) Susceptible to:
AMK
AMP/
SAM
CFZ CTX CIP ERY GEN MEM OXA PEN TZP RIF TMP VAN
E. coli (28) 4
(14)
9
 (32)
5
(18) 
8
(28)
0
(0 )
0
(0 )
14
(50 )
3
(11)
0 
(0 )
0 
(0 )
8
(29 )
0
(0 )
4
(14 )
0
(0 )
Klebsiella 
(12) 3 (25)
7
 (58) 
4
(33) 
8
(67)
0
(0 )
0
(0 )
12
(100 )
2
(17)
0
(0 )
0
(0 )
4
(33) 
0
(0 )
2
(17) 
0
(0 )
S. aureus
(10) 1 (10)
5
 (50)
2
(20)
4
 (40 )
9 
(90 )
9
(90 )
3
(30 )
1
(10 )
10
(100 )
3
 (30 )
10
 (100) 
5 
(50 )
3
(30 )
10
(10 )
AMK: Amikacin; Ampicillin+ sulbactam: AMP/SAM; Cefazolin: CFZ; Cefotaxime: CTX; Ciprofloxacin ; CIP; Clindamycin: CLI; Erythromycin: 
ERY; Gentamycin: GEN; Imipinem: IPM; Meropnem: MEM; Oxacillin: OXA; Penicillin: PEN; Piperacillin/tazobactam: TZP; Rifampicin: RIF; 
Trimethoprim: TMP; Vancomycin: VAN.
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However, it is to be emphasized that the etiology 
of gram positive cocci in SBP has markedly increased 
recently.Streptococci (mostly pneumococci), have 
been found to  be common organisms in patients 
who are not receiving selective intestinal decon-
tamination [18]. S. aureus  is an emergent bacteria 
in patients who have been treated with antibiotic 
prophylaxis (quinolones) and/or underwent invasive 
procedures [19-20]. S. aureus  accounted for 20% 
of isolated organisms in the present work, which is 
comparable to other studies [19], but is less than 
report given by Fernandez et al., [20]. No obligate 
anaerobes were isolated as in other studies. The 
reduced capability of intestinal anaerobes for trans-
location and the relatively high oxygen content of 
ascitic fluid are considered inhibiting factors [21].
Reputable organizations have recommended 
several antibiotics that might be used for empirical 
treatment in community based SBP. In a nosoco-
mial setting patient should receive empiric antibi-
otic therapy according to the local susceptibility of 
bacteria. This is of particular concern due to recent 
changes in the microbial flora of SBP, and increased 
incidence of antibiotic- resistant gram-negative bac-
teria mostly due to the widespread usage of qui-
nolones for prophylaxis. With appropriate antibiotic 
treatment of SBP, infection-related mortality can ap-
proach zero [22].
Hepatocellular carcinoma was identified as a risk 
factor; an anticipated issue due to the negative ef-
fect of HCC on the immune system. 
We found no relation between prior use of 
Table 4. Comparison of clinical and demographic characteristics for SBP and non SBP
Significance 
Non SBP
No=83
SBP
No=106
Characteristics
0.13*58.7±10.7(36-89)61.5±14.5(30-94)Age(years):mean±SD (Range)
0.5**
54 (45.8)
29 (40.8)
64 (54.2)
42(59.2)
Male: N (%)
Female: N (%)
0.47**32(47.8)35(52.2)Smokers: N (%)
0.38*20.6±10.3(6-54)21.8±9.2(8-45)MELDscore:mean±SD (Range)
0.51**36(41.4)51(58.6)Associated infection: N (%)
0.1*172.8±92193.5±114Random blood glucose (mg\dl):mean±SD
0.013**
0.66**
0.004**
0.42**
23(32.4 )
6(50 )
26(63.4 )
32(47.8 )
48(63.6)
6(50)
15(36.6 )
35(52.2 )
Risk factors: N (%)
HCC 
PPI 
BB 
 Diabetes 
0.001**
0.2**
0.08**
0.36**
0.003**
27(30.7 )
30(38.5) 
14(6.09)
21(50)
21(67.7)
61(69.3 )
48(61.5)
9(39.1)
21(50)
10(32.3 )
Complaint: N (%)
 Fever: 
 Abdominal pain 
G I bleeding 
H.E. 
Hypotension at presentation: N (%)
0.64*9.7±2.3(7-15)9.6±2.3(7-15)Child-pugh score: mean±SD(Range)
0.09*17.1±5.118.1±7.6Prothrombin time(seconds):mean±SD
0.42**1.5±0.51.4±0.6INR: mean±SD
Abbreviations; MELD: Model for End stage Liver Disease, PPI: proton pump inhibitor, HCC: hepatocellular carcinoma, BB: beta blocker, GI: 
gastro-intestinal, HE: hepatic encephalopathy, Level of significance calculated b *: t- test **: X2test
 This article is available from: www.iajaa.org / www.medbrary.com 
THE INTERNATIONAL ARABIC JOURNAL OF ANTIMICROBIAL AGENTS
ISSN 2174-9094
2016
Vol. 6 No. 2:5
doi: 10.3823/790
© Under License of Creative Commons Attribution 3.0 License 7
proton pump inhibitor (PPI) and SBP as reported 
by similar studies [23]. Additionally, patients using 
Beta blockers (BBS) were less liable to develop SBP; 
however such medication had nothing to do as a 
differentiating factor for presenting with a specific 
SBP variant. BBS prevent variceal bleeding through 
decreasing portal pressure which is theoretically 
supposed to benefit patients. Reducing portal hy-
pertension may decrease intestinal translocation of 
microorganisms into the peritoneal cavity [25]. In 
contrast, other studies have identified Beta blockers 
use as an independent risk factor for death [26]. 
These contradictory conclusions require more inves-
tigations before BBS use can be endorsed for the 
routine management of ascites. 
Fever and hypotension were significantly asso-
ciated with diagnosis of SBP among our patients. 
Contrary to earlier studies, abdominal pain was a 
symptom significantly associated with the CNNA. 
Total leukocytic count is significantly higher in CNNA 
than classic type. This result could lead to better 
ability of ascetic fluid to remove bacteria leading 
to the CNNA variant, a finding that needs further 
studies.
Table 5. Comparison of clinical and demographic characteristics for SBP variants
Significance
CNNA
No=56
Classic SBP
No=50
Characteristics
0.91*61.4±15.261.7±14Age(years):mean±SD
0.74**
33(58.9)
23(41.1)
31(62) 
19(38)
Male: N (%)
Female: N (%)
0.3**40(71.4)19(38)Smoking: N (%)
0.002**
0.15**
0.28**
0.83**
33(58.9)
1(1.8)
6(10.7)
18(32.1)
15(30)
5(10)
9(18)
17(34)
Risk factors: N (%)
HCC 
PPI 
BB 
 Diabetes 
0.81*9.6±2.39.5±2.2Child-pugh score: mean±SD
0.001**
0.001**
0.85**
0.13**
0.6**
42(75)
39(69.6 )
5(8.9 )
8(14.3 )
4(7.1 )
19(38.0 )
9(18.0 )
4(8 )
13(26) 
6(12)
Complaint: N (%)
Fever 
Abd. Pain 
G I bleeding 
HE 
Hypotension at presentation 
0.67**28(50)23(46.0%)Associated infections: N (%)
0.69*197.7±115.2188.9±113.Random blood sugar(mg/dl):mean±SD
0.71*1608±13211695.5±1081Total protein(g/dl):mean±SD
0.02*1767.3±18141136±667Total leucocytic count(cells/µl):mean±SD
0.29*19.5±9.017.9±5.7Prothrombin time(seconds):mean±SD
0.19*1.36±0.51.52±0.7INR: mean±SD
0.1*159.0±164.1211.2±161.LDH(IU/l):mean±SD
0.69*197.7±115.2192±153Glucose(mg/dl):mean±SD
0.815*897.4±813.7865.7±527Neutrophilcount(cells/µl):mean±SD
Abbreviations; MELD: Model for End stage Liver Disease, PPI: proton pump inhibitor, HCC: hepatocellular carcinoma, BB: beta blocker, GI: 
gastro-intestinal, HE: hepatic encephalopathy
Level of significance calculated by
*: t- test, **: X2test
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When analyzing data for outcomes of SBP versus 
non-SBP, a higher mortality rate in patients with 
the SBP was evident, and it was consistent with 
the other findings [27]. Mortality rates of SBP cases 
are vary between 20% to 70% [28]. Mortality be-
ing generally due to complications such as acute 
variceal bleeding, development of the hepatorenal 
syndrome or progressive liver failure. With advances 
in diagnosis and treatment, mortality from SBP is 
expected to be decreasing. Risk factors of mortality 
among SBP patients were analyzed using multivari-
ate regression model. Age and MELD score were 
the only independent risk factors for such events, 
and this finding is much similar to other reports [29]
Conclusions 
Spontaneous bacterial peritonitis is occurring at 
high frequency among cirrhotic patients admitted 
to the Medical ICU of Zagazig University hospital. 
This serious complication should be detected with-
out delay, since prompt diagnosis and treatment 
result in decreased morbidity and mortality among 
infected patients. This study provides guidelines for 
selecting antibiotics for empirical therapy of patients 
with SBP in our hospital and region. 
References
 1. Stiburek O, Kopacova M, Lata J. Spontaneous bacterial 
peritonitis: a severe complication of liver cirrhosis. World J 
Gastroentero 2009; 2(5): 3 -9l
 2. Gaya DR, David B, Lyon T, et al .Bedside leucocyte esterase 
reagent strips with spectrophotometric analysis to rapidly 
exclude spontaneous bacterial peritonitis: apilot study. Eur J 
Gastroenterol Hepatol 2007; 19: 289-295.
 3. Koulaouzidis A, Bhat S, Saeed AA. Spontaneous bacterial 
peritonitis. World J. Gastroenterol. 2009; 15 (9): 1042–9.
 4. Navasa M , Rodes J. Management of ascites in the patient with 
portal hypertension with emphasis on spontaneous bacterial 
peritonitis. Semin Gastrointest Dis 1997; 8(4): 200-9
 5. Riggio O, Angeloni S. Ascitic fluid analysis for diagnosis and 
monitoring of spontaneous bacterial peritonitis. World J 
Gastroenterol 2009;15(31): 3845-50.
 6. Acevedo J, Fernandez J, Castro M, et al. Current efficacy of 
recommended empiric therapy in patients with cirrhosis and 
bacterial infection. J Hepatol 2009; 50 suppl: 1: 55
 7. Gines P, Rimola A, Planas R, et al. Norfloxacin prevents 
spontaneous bacterial peritonitis recurrence in cirrhosis: results 
of a double –blind placebo-controlled trial. Hepatology 1990; 
12: 716-24.
 8. Child CG, Turcotte JG. Surgery and portal hypertension. Major 
Probl Clin Surgery 1964;1:1-85
 9. Clinical and Laboratory Standards Institute (CLSI): Body fluid 
analysis for cellular composition, approved guideline. CLSI 
document H56-A, Wayne, PA, 2006 .
10. Clinical and Laboratory Standards Institute (CLSI). Performance 
standards for antimicrobial susceptibility testing. 23nd 
Informational Supplement. M100-S23. Wayne, PA: CLSI, 2013. 
11. Iqbal S, Iman N, andAlam N. Incidence of spontaneous 
bacterial peritonitis in liver cirrhosis, the causative organisms 
and antibiotic sensitivity. JPMI 2004; 18:614-9
12. Saqib A, Masood Z Khan RR, Haque I. Frequency of spontaneous 
bacterial peritonitis in cirrhotic patients with ascites due to 
hepatitis B and C. JUMDC 2012;3(1)22-3.
13. Amjad Z, Rahida K, Rashid M, et al. Frequency and microbial 
spectrum of Spontaneous bacterial peritonitis in established 
cirrhotic liver. J Ayub Med Coll Abbottabad 2011; 32(4):15-17.
14. Nepal N, Pande PR , Khatri R. Study of frequency of spontaneous 
bacterial peritonitis in patients with alcoholic cirrhosis with 
ascites. Postgrad Med J NAMS 2009; 9(2)45-49.
15. Bandy SM, Tuttle A. Spontaneous bacterial peritonitis. 
E-medicine from WebMD. Updated July 16, 2008.Last cited 
Dec 25th 2015
16. Bhuva M, Ganger D, Jensen D. Spontaneous bacterial peritonitis: 
An update on evaluation, management, and prevention. Am J 
Med  1994;97:169–75
 17. Sheer TA, Runyon B.A. Spontaneous bacterial peritonitis. Dig 
Dis 2005; 23(1): 39-46.
18. Garcio-Tsao G. Bacterial infection in Cirrhosis: treatment and 
prophylaxis. J Hepatol 2005;42(S): 585-92.
19. Such J, Runyon A. Spontaneous bacterial peritonitis. Clin Infect 
Dis 1998;27:669–76
20. Fernandez J, Navasa M, Gomez J. et al. Bacterial infections in 
cirrhosis: Epidemiologic changes with invasive procedures and 
norfloxacin prophylaxis. Hepatology 2002; 35:140–48.
21. Scheckman P, Onderdonk AB, Bartlett JG. Anaerobes in 
spontaneous peritonitis (letter) Lancet 1977; 2:1223
22. Lolekha P , Chunlertrith K. Spontaneous bacterial peritonitis, 
causes and antibiotic usage in Srinagarind hospital. J Med 
Assoc Thai 2001;84(7):995-9
23. Sersté T, Melot C, Francoz C, Durand F, et al. Deleterious effects 
of beta-blockers on survival in patients with cirrhosis and 
refractory ascites. Hepatology. 2010;52:1017-22.
24. RatelleM ,Perreault S, Villeneuve JP , Tremblay L. Association 
between proton pump inhibitor use and spontaneous bacterial 
peritonitis in cirrhotic patients with ascites. Can J Gastroenterol 
Hepatol 2014 ; 28(6): 330–34
25. Hernández-Gea V, Aracil C, Colomo A, et al. Development of 
ascites in compensated cirrhosis with severe portal hypertension 
 This article is available from: www.iajaa.org / www.medbrary.com 
THE INTERNATIONAL ARABIC JOURNAL OF ANTIMICROBIAL AGENTS
ISSN 2174-9094
2016
Vol. 6 No. 2:5
doi: 10.3823/790
© Under License of Creative Commons Attribution 3.0 License 9
treated with beta;-blockers. Am J Gastroenterol 2012;107:418-
27.
26. De Vos M, De Vroey B, Garcia Garcia B, et al. Role of proton 
pump inhibitors in the occurrence and the prognosis of 
spontaneous bacterial peritonitis in cirrhotic patients with 
ascites. Liver Int 2013;33:1316–23
 27. Bankar S, De A and Baveja S. Comparison of three culture 
methods for diagnosis of Spontaneous Bacterial Peritonitis 
(SBP) in adult patients with cirrhosis Int J Curr Microbiol App Sci 
2014.3(7): 156-160.
28. Thanopoulou AC, Koskinas JS, Hadziyannis SJ. Spontaneous 
bacterial peritonitis (SBP):clinical, laboratory, and prognostic 
features. A single-center experience. Eur J Intern Med. 
2002;13(3):194-8.
29. Thiele GB, Silva OM , Fayad L, LazzarottoC, Ferreira MA, 
Marconcini M L et al., Luz. Clinical and laboratorial features of 
spontaneous bacterial peritonitis in southern Brazil. Sao Paulo 
Med J (2014): 132(4), 205-10. https://dx.doi.org/ 10.1590/1516-
3180.2014.1324698
Where Doctors exchange clinical experiences,  
review their cases and share clinical knowledge.  
You can also access lots of medical publications for 
free. Join Now! 
http://medicalia.org/
Comment on this article:
The Journal is an open access peer-reviewed journal that 
publishes scientific papers about all aspects of antimicrobials. 
The journal will publish original research articles, reviews, 
brief reports and case reports dealing with basic and 
clinical antibacterial agents, antiviral, antiprotozoals, 
antituberculuous, antifungal and antihelminthes agents.
All manuscripts must be prepared in English, and are 
subject to a rigorous and fair peer-review process. Accepted 
papers will immediately appear online.
The journal aims to advance the knowledge, attitude 
and the research of chemotherapy in the Arabic world in 
cooperation with international, national scientific and public 
societies as well as research centers with similar aims and 
objectives.
Publish with iMedPub
http://www.imed.pub
